28
February
0
Comments
Genetics Co. Raises $191M In Venture Funding
in Legal News
Law360 (February 28, 2019, 4:13 PM EST) — Maze Therapeutics, a company focused on translating genetic research into new medicines, said Thursday it has raised $191 million in venture capital led by investments from Third Rock Ventures and ARCH…
